Investing.com - Zai Lab reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Zai Lab announced earnings per share of $-0.3982 on revenue of $5.2M. Analysts polled by Investing.com anticipated EPS of $-0.9899 on revenue of $7.4M.
Zai Lab shares are up 158.93% from the beginning of the year and are trading at $107.69 , down-from-52-week-high.They are outperforming the Nasdaq which is up 37.63% from the start of the year.
Zai Lab follows other major Healthcare sector earnings this month
Zai Lab's report follows an earnings beat by Medtronic on Tuesday, November 24, 2020, who reported EPS of $1.02 on revenue of $7.65B, compared to forecasts EPS of $0.8033 on revenue of $7.1B.
Bristol-Myers Squibb had beat expectations on Thursday, November 5, 2020 with third quarter EPS of $1.63 on revenue of $10.54B, compared to forecast for EPS of $1.49 on revenue of $10.32B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar